Table 1:
Category | number | |||
---|---|---|---|---|
| ||||
Age, median [years (range)] | 52 (25–69) | |||
Biological Sex | Male | 16 | ||
Female | 9 | |||
Diagnosis at HCT | ||||
AML | 20 | |||
2` secondary AML | 8 | |||
1` primary AML | 12 | |||
MDS | refractory | 1 | ||
ALL | 4 | |||
T-cell ALL | 2 | |||
CML transformed to Ph+ ALL | 1 | |||
B-cell ALL | 1 | |||
Prior Allo-HCT | 7 | |||
Risk Group - by ELN | 2017 Criteria | |||
2` AML | Favorable | 0 | ||
Intermediate | 4 | |||
High | 4 | |||
1` AML | Favorable | 1 | ||
Intermediate | 9 | |||
High | 2 | |||
MDS | High | 1 | ||
ALL | High | 4 |